Acciones LexaGene Holdings Inc. Toronto S.E.
Acciones
LXG.H
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,06 % | 9586,32 M | |
-4,99 % | 3210,97 M | |
+27,68 % | 2918,66 M | |
-13,96 % | 2151,24 M | |
-15,45 % | 1788,88 M | |
+71,68 % | 1474,42 M | |
+24,84 % | 770 M | |
-2,62 % | 761 M | |
-24,69 % | 548 M |